About this trial
Shoulder osteoarthritis (OA) is a frequent problem in our aging population and is believed to occur in up to 20% of the population. Different types of glenoid morphology are associated with shoulder OA, depending on the amount and localization of the glenoid erosion as well as the amount and direction of Humeral Head Migration.
Total shoulder arthroplasty (TSA) has been shown to relieve the pain and improve joint function of patients with OA. However, several complications such as component loosening and polyethylene damage has been reported and it has been revealed that 7.3% of glenoids may show signs of asymptomatic radiographic loosening annually after primary anatomic TSA. The mechanism of such fixation failure is still unclear.
The main goal of this study is evaluating in-vivo glenohumeral contact patterns in patients with osteoarthritic glenoids before and after TSA, to unravel the high rate of glenoid component loosening.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients with glenohumeral osteoarthritis planned for anatomic shoulder arthroplasty in the University Hospitals Leuven, Belgium
Complete patient informed consent
Pain free at the time of EOS imaging
Healthy adult volunteers with no history of shoulder pain or trauma
Disqualifiers
None
Trial population
Both OA patients and Healthy control group are screened in UZ Leuven for the prospective part of this study. Revised TSA patients because of glonoid component loosening are screened for the retrospective part of the study.
Trial design
Cohort
Other
Treatments tested in this trial
Stereo Radiographic EOS Measurements
RadiationHealthy control will undergo a stereo radiographic EOS exam with their arm in various positions. 1. Relaxed standing (0 degree of abduction) 2. 45 degree of abduction in the coronal plane 3. 90 degree of abduction in the coronal plane 4. 120 degree of abduction in the coronal plane 5. 45 degree anterior flexion in the sagittal plane 6. 90 degree anterior flexion in the sagittal plane 7. 120 degree of anterior flexion in the sagittal plane 8. 45 degree extension in the sagittal plane
Treatment groups
Trial outcomes
Primary outcomes
Compere In-vivo glenohumeral joint contact patterns in patients using EOS stereo radiographic imaging
Evaluating in-vivo glenohumeral joint contact patterns in patients with different type of osteoarthritic glenoids pre- and post-TSA. Glenohumeral contact areas are compared before and after surgery in patients with osteoarthritic glenoids, using EOS stereo radiographic imaging
Compere in-vivo glenohumeral joint contact patterns in healthy subjects using EOS stereo radiographic imaging
Evaluating glenohumeral joint contact patterns in healthy subjects and comparing them with patients with osteoarthritic glenoids before patients receive surgery and after patients receive surgery. Glenohumeral contact areas are compared using EOS stereo radiographic imaging
Pre-operative factor: Humeral Head Migration
Identifying probable pre-operative factors; for example the amount of HHM; on glenohumeral contact area after surgery using pre- and postoperative CT scans.
Pre-operative factor: Inclination and rotator cuff muscle's quality
Identifying probable pre-operative factors; for example the inclination and rotator cuff muscle's quality; on glenohumeral contact area after surgery using pre- and postoperative CT scans.
Secondary outcomes
Variations in glenohumeral contact areas
Determining possible variations in glenohumeral contact areas among patients with different type of osteoarthritic glenoids (A, B, C and D glenoids).
Influence of the location of the glenohumeral contact pattern
Evaluate the influence of the location of the glenohumeral contact area and amount of their deviations from healthy subjects on the long-term outcome and survival of the glenoid component. Pre-operative and 2 years after surgery, a CT scan from OA group will be obtained , which will be used for evaluating long-term outcome and survival of the glenoid component .
Sponsors and contacts
Click on the lead sponsor to view all of their trials.